🇺🇸

US SEC Filing Intelligence

· daily

Significant Contract Modifications ($10M+) — August 12, 2026

This digest covers four significant contract modifications totaling $615.8 million, with only one of four being defense-related (the Department of Homeland Security award to Jacobs Engineering), indicating a civilian-heavy procurement period. The dominant sector theme is healthcare and social services, with two large HHS awards (Palmetto GBA at $212.5M and Roche at $183.8M) and a VA award to Leidos (QTC Medical Services) at $113.9M. The highest-conviction signal is the bullish VA award to Leidos, where 92% of the $113.9M has already been outlaid, reflecting strong execution and stable demand. A key risk is the large outlay gap in the Palmetto GBA contract ($212.5M obligated but only $14.6M outlaid), which may signal execution or funding issues ahead of its September 2024 expiration.

4 total filings
· daily

Contract Deobligations Alert — August 12, 2026

The August 12, 2026 contract deobligations digest reveals $615.8 million in total obligations, with only 1 of 4 contracts defense-related, underscoring a civilian-heavy federal procurement environment. The dominant theme is healthcare and administrative services, with HHS (CMS and BARDA) accounting for $396.4 million (64%) of the total, while DHS/CBP and VA contribute $105.6 million and $113.9 million respectively. The highest-conviction signal is Leidos' (via QTC Medical Services) $113.9 million VA disability exam contract, which shows 92% outlay and a bullish outlook due to mandated demand. Key risks include Jacobs' high execution risk on a firm-fixed-price border infrastructure contract and Palmetto GBA's low outlay rate (7%) despite a $212.5 million obligation, suggesting potential funding or performance issues. Investors should watch for option exercises on Jacobs' contract and re-competition of Palmetto GBA's CMS contract post-2024.

4 total filings
· daily

Contract Option Exercises — August 12, 2026

The four contracts analyzed represent $615.8 million in total obligations, with a 1/4 defense-related split (all civilian agencies: HHS, VA, DHS). The dominant theme is stable, long-duration civilian agency spending on healthcare administration (Palmetto GBA at $212.5M), biodefense R&D (Roche at $183.8M), veteran medical exams (Leidos/QTC at $113.9M), and border security infrastructure (Jacobs at $105.6M). The highest-conviction signal is Leidos' near-complete revenue realization (92% outlay rate) on its VA medical exam contract, indicating strong execution and recurring demand. Key risk: Jacobs' firm-fixed-price border station contract carries high execution risk on 11 design-build projects, with potential cost overruns.

4 total filings
· daily

Federal Professional Services Contracts — August 12, 2026

The sole contract in this digest is a $105.6 million firm-fixed-price BPA call awarded to Jacobs Engineering Group Inc. (via subsidiary STG LLC) from the Department of Homeland Security's Customs and Border Protection for construction management advisory services on 11 border patrol station projects across four states. This is a 100% civilian contract, with zero defense exposure, signaling a continuation of DHS investment in border security infrastructure through 2031. The highest-conviction signal is the neutral-to-bullish multi-year revenue visibility for Jacobs, though the fixed-price structure introduces high execution risk on 11 large design-build projects. Key watch items include option exercises to bring total value to $162.3 million and any shifts in border security policy that could impact future DHS contract obligations.

1 total filings
· daily

All HHS Contracts — August 12, 2026

The two HHS contracts analyzed total $396.4 million in obligations, with a 50/50 defense-civilian split (one BARDA biodefense contract, one CMS administrative contract). The dominant theme is stable, multi-decade funding for healthcare administration and biodefense R&D, but both contracts show low execution velocity—Palmetto GBA's $212.5M CMS contract has only $14.6M outlaid over 16 years, and Roche's $183.8M BARDA contract is cost-no-fee, limiting profit contribution. The highest-conviction signal is the potential re-compete of Palmetto GBA's contract after September 2024, which could disrupt a long-standing incumbent relationship. Key risk: the large gap between obligated and outlaid funds for Palmetto GBA suggests either delayed revenue recognition or program under-execution, warranting close monitoring.

2 total filings
· daily

Mega Contracts Monitor ($100M+) — August 12, 2026

This digest covers $615.8 million in total obligations across four contracts, with only one of four being defense-related (25%), reflecting a civilian-heavy mix dominated by HHS ($396.4M combined) and DHS ($105.6M). The highest-conviction signal is the Leidos Holdings (via QTC Medical Services) $113.9M VA contract, which is 92% outlaid, indicating near-complete revenue realization and strong execution in a stable, legally mandated program. The dominant theme is stable, long-duration civilian agency spending on healthcare administration and biodefense R&D, but the Palmetto GBA contract's massive $197.9M gap between obligated and outlaid funds raises questions about revenue recognition and execution pace. Key risk: the Jacobs Engineering $105.6M firm-fixed-price border infrastructure contract carries high pricing risk given the 11-project scope and potential for cost overruns.

4 total filings
· daily

High-Value Federal Grants ($5M+) — August 12, 2026

This digest covers $615.8 million in high-value federal grants, with a 1:3 defense-to-civilian split, dominated by civilian health agencies (HHS and VA). The highest-conviction signal is a bullish one for Leidos Holdings via its QTC Medical Services subsidiary, which secured a $113.9 million VA contract with a 92% outlay rate, indicating strong execution and recurring revenue. The dominant sector theme is stable, long-term civilian healthcare administration and R&D, with Palmetto GBA's $212.5 million CMS contract and Roche's $183.8 million BARDA award providing multi-year visibility. Key risks include execution risk on Jacobs Engineering's $105.6 million fixed-price DHS border contract and the large gap between obligated and outlayed funds on the Palmetto GBA contract, which may signal funding delays or underperformance.

4 total filings
· daily

General Federal Contracts — August 12, 2026

This digest covers $615.8 million in total obligations across four civilian agency contracts, with only one of four being defense-related (VA), underscoring a healthcare and homeland security bias. The highest-conviction signal is Leidos Holdings' $113.9 million VA medical exam win (92% outlaid), indicating strong execution and recurring revenue from a mandated program. The dominant theme is stable, long-duration HHS funding (Palmetto GBA, Roche) offset by execution risk in DHS border infrastructure (Jacobs Engineering). A key risk is the $197.9 million outlay gap on Palmetto GBA's 16-year contract, suggesting potential funding or performance delays. Overall, the digest points to civilian healthcare and border security as durable pockets, but with limited defense exposure and no clear competitive moats.

4 total filings
· daily

S&P 500 Technology Sector SEC Filings — August 12, 2026

The 16 filings from the S&P 500 Technology sector reveal a powerful bifurcation: AI infrastructure leaders like Cisco are delivering record revenue and surging AI orders, while insider selling at KLA, Datadog, and CrowdStrike signals caution at elevated valuations. Cisco's standout Q4 FY2026 results—revenue up 18% YoY to $17.3B and AI orders of $4B—underscore the AI capex boom, but flat services revenue and cash flow suggest margin pressure. Insider activity is a dominant theme: KLA's CEO and President sold a combined $24M, CrowdStrike's CEO sold $1.07M, and Datadog's CTO sold $2.09M, all under 10b5-1 plans, while Cisco executives had routine tax-withholding sales. The absence of dividend or buyback changes across filings points to reinvestment over shareholder returns. Key risks include KLA's heavy insider selling, CrowdStrike's CEO sales amid competitive pressure, and Palantir's large insider gift. Opportunities center on Cisco's AI momentum and strong guidance, while Synopsys's GC departure is a minor governance watch item.

14 high priority 2 medium 16 total filings
· daily

Nasdaq 100 Stocks SEC Filings — August 12, 2026

The 23 filings from NASDAQ-100 constituents reveal a market bifurcated between AI infrastructure hyperscalers and mature tech stalwarts. CoreWeave's 10-Q shows explosive revenue growth (112% YoY) but a sharp swing to operating losses, massive debt accumulation ($35B), and heavy customer concentration, signaling a high-risk, high-reward AI buildout. In contrast, Cisco's record Q4 FY2026 results (revenue +18% YoY, EPS +52%) and raised AI infrastructure guidance ($9.3B in FY orders) demonstrate profitable AI monetization. Insider activity is a key signal: CoreWeave's Chief Development Officer sold nearly $11M in shares via 10b5-1 plans, while Meta's COO and Qualcomm's CFO also executed sales, contrasting with routine tax withholdings at Cisco and Amgen. Capital allocation trends show Cisco generating strong cash flows, while Intel raised $23B via a dilutive equity offering to fund its turnaround. The period-over-period data highlights a clear winner in networking (Cisco) and a capital-intensive, cash-burning challenger in cloud compute (CoreWeave).

16 high priority 7 medium 23 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — August 12, 2026

The August 12, 2026, batch of 50 SEC filings is dominated by routine, passive institutional ownership updates (13G filings), with Norges Bank, AQR Capital Management, and Hotchkis & Wiley being the most active filers. The most significant actionable signals are two complete exits by activist-adjacent funds (Iroquois from XWELL, 683 Capital from Perceptive Capital Solutions) and one significant restructuring by HHCF in Katapult Holdings, converting preferred equity into debt and common stock. While most filings show no change in ownership or intent, the aggregate data reveals a strong, passive institutional presence in sectors like REITs (Kilroy, Federal Realty, Digital Realty, BXP) and large-cap tech (Atlassian, Workday, Duolingo). The key takeaway is a lack of new activist campaigns, but the exits and restructuring provide clear, actionable signals of changing investor conviction in specific names. The period-over-period data is limited, as most filings are amendments with no change or are initial filings, but the few changes (Vanguard increasing in H&R Block, Norges Bank shifting composition in New Oriental) offer subtle clues of institutional accumulation and rebalancing.

2 high priority 48 medium 50 total filings
· daily

S&P 500 Financials Sector SEC Filings — August 12, 2026

The six filings from the S&P 500 Financials sector reveal a mixed picture of capital management and insider sentiment. A dominant theme is the active use of capital markets by major institutions: JPMorgan Chase reported a massive $18.07B portfolio with significant options activity, while American Express created a new $1.6B preferred share series to bolster its capital structure. However, this activity is contrasted by notable insider selling, with the President of Allstate executing a large net sale of ~$9.7M worth of stock after exercising options, and an Aflac director making a smaller sale. The T. Rowe Price OHA Select Private Credit Fund's tender offer, which saw only 57.4% participation and was settled via promissory notes, signals potential liquidity or valuation concerns in the private credit space. U.S. Bancorp's 13F filing, focused on non-U.S. equities, shows a more conservative, diversified portfolio. The overall sentiment is cautious, with capital being raised or returned to shareholders through specific mechanisms, while insiders at two major insurers are reducing their exposure, warranting close monitoring for broader sector trends. No period-over-period comparisons were available in these filings to establish growth or margin trends. No forward-looking guidance was provided in these filings to build a catalyst calendar. No capital allocation changes (dividends, buybacks) were announced in these filings. No M&A transactions were reported in these filings. No financial ratios or operational metrics were provided in these filings. No scheduled events were mentioned in these filings.

4 high priority 2 medium 6 total filings
· daily

S&P 500 Energy Sector SEC Filings — August 12, 2026

The three filings from the S&P 500 Energy sector on August 12, 2026, reveal a sector marked by divergent insider sentiment and passive institutional positioning. APA Corp's 13G/A filing shows a major passive holder, Hotchkis & Wiley, maintaining a significant 8.97% stake, indicating steady institutional confidence without active control intent. In contrast, Phillips 66's Form 4 filings signal a strong bearish insider signal: Executive VP Mandell Brian executed a net sale of $4.9M in stock, including a large $6.45M sale, which may reflect personal portfolio diversification or a lack of conviction in near-term valuation. Texas Pacific Land Corp saw a minimal insider purchase of 1 share by a 10% owner, a token gesture that does not offset the broader negative signal from Phillips 66. Period-over-period data was not available in these filings, limiting trend analysis, but the insider activity pattern suggests a cautious outlook among senior executives at a major refiner, while passive funds remain committed to upstream E&P names like APA.

2 high priority 1 medium 3 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — August 12, 2026

The Consumer Staples sector is showing a clear pattern of insider profit-taking and capital recycling, with three major filings (McCormick, Church & Dwight, Hershey) revealing significant insider sales totaling over $12.3 million. The most notable is McCormick's former Executive Chairman Lawrence Kurzius, who exercised and immediately sold 205,538 shares ($10.8M), reducing his stake to 1.6% of the company, a signal of reduced conviction at the top. Hershey's 10% owner (Milton Hershey School Trust) also systematically sold shares under a 10b5-1 plan, indicating a planned liquidity event. In contrast, Estée Lauder's passive 7.5% stake filing by Managed Account Advisors suggests institutional confidence in the beauty giant's long-term value. ADM's board resignation is a non-event, but the timing (year-end 2026) adds a minor governance transition risk. Overall, the sector is experiencing insider de-risking, with no major bullish capital allocation signals (buybacks, dividends) reported, pointing to a cautious near-term outlook.

6 high priority 1 medium 7 total filings
· daily

S&P 500 Industrials Sector SEC Filings — August 12, 2026

The latest batch of 10 filings from the S&P 500 Industrials stream reveals a pronounced divergence in management and major shareholder sentiment across the sector. While the overall filing activity is dominated by insider transactions (Form 4 filings) and passive institutional ownership disclosures (Schedule 13G), the data points to a clear pattern of **c-suite profit-taking** at General Dynamics, GE, and Emerson Electric, contrasting sharply with a massive **$45.8M insider buy** at Republic Services. The period-over-period data is sparse in these specific filings, but the insider activity provides a powerful, real-time signal on management conviction. The most actionable intelligence comes from the insider trading patterns, which suggest a bearish tilt among executives at legacy industrial conglomerates, while a major 10% owner is aggressively accumulating shares in the waste management sector. The institutional filings (13G/A) show passive, large-scale ownership in Carrier Global and Northrop Grumman, indicating stable, long-term institutional interest. The UPS debt issuance filing is a routine capital markets transaction with no performance implications. The Lockheed Martin 13F-HR provides a window into corporate treasury allocation, showing a heavy tilt towards mega-cap tech and broad market ETFs, a neutral but informative data point on internal capital allocation views.

5 high priority 5 medium 10 total filings
· daily

US Material Events SEC 8-K Filings — August 12, 2026

The August 12, 2026 filings reveal a market actively managing balance sheets through refinancing, capital raises, and strategic M&A, while corporate governance changes and restatements signal underlying stress. Key themes include liability management (Charter, American Airlines, Southwest), equity issuance for growth and liquidity (Ryman, Sky Harbour, ACRES), and transformative M&A (AEVEX, Modiv/GNL). Financial performance is mixed: OptimizeRx and Stem show revenue declines but margin improvements, while Crown Crafts and PubMatic show positive trends. Insider activity is limited, but notable director departures at SPAR Group and a CFO change at BitGo warrant attention. Forward-looking guidance is largely reaffirmed, with key catalysts including ArriVent's Phase 3 data and AEVEX's acquisition close. Overall, the digest points to a cautious but active corporate environment, with selective opportunities in companies demonstrating operational resilience and strategic clarity.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — August 12, 2026

The August 12, 2026 batch of Dow 30 filings reveals a bifurcated picture: robust AI-driven growth at Cisco contrasts with leadership uncertainty at Home Depot and insider selling at Merck. Cisco's record Q4 revenue ($17.3B, +18% YoY) and raised AI guidance ($4B in Q4 orders) underscore a powerful secular tailwind, while its management's routine tax-withholding insider transactions are neutral. However, a material risk flag emerges from Merck, where the Animal Health President sold ~$4.4M in stock, signaling potential concern. Home Depot's CEO medical leave introduces short-term operational risk, though the company's succession plan is orderly. JPMorgan's 13F reveals a $7.26B long position in AbbVie, a bullish signal for the pharma sector. Across the board, insider activity is largely neutral (tax withholdings), but the lack of open-market buying is notable. The key themes are AI infrastructure acceleration, pharma insider divergence, and consumer/industrial leadership stability.

13 high priority 3 medium 16 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — August 12, 2026

Both filings on August 12, 2026, reveal acute distress in micro-cap companies listed on Nasdaq, with CID Holdco (Dot Ai) and Generation Income Properties facing imminent delisting due to market value and bid price deficiencies. The common theme is a failure to maintain minimum listing standards despite prior compliance efforts, signaling severe liquidity and market confidence issues. CID Holdco's stock has collapsed in value, failing to meet the $50M MVLS threshold, while Generation Income Properties cannot sustain a $1.00 bid price and now faces a compounding equity deficiency. Neither company has shown any period-over-period revenue growth or margin improvement in the enriched data, and both lack insider buying or positive forward guidance, reinforcing a bearish outlook. The market implications are binary: delisting would likely trigger further price declines and loss of institutional access. These cases highlight a broader trend of struggling micro-caps unable to reverse valuation erosion in a selective market environment.

2 high priority 2 total filings
· daily

Global High-Priority Regulatory Events — August 12, 2026

The August 12, 2026 digest is dominated by a wave of corporate distress and restructuring, with 12 filings related to insolvency, bankruptcy, or delisting, and 20 filings involving mergers, acquisitions, or business combinations. The most critical development is the convergence of multiple high-risk events: Simbhaoli Sugars' deepening insolvency with an adverse audit opinion, the forced delisting of CID Holdco (Dot Ai) and Agriculture & Natural Solutions Acquisition Corp, and the Nasdaq non-compliance of Generation Income Properties. On the M&A front, the completion of Modiv Industrial's merger with Global Net Lease and the SEC effectiveness of the Inflection Point Acquisition Corp. V / GOWell business combination signal active SPAC consolidation. A notable trend is the aggressive expansion of Indian companies into new subsidiaries and joint ventures, with 10 filings detailing new incorporations or stake acquisitions, often in early-stage entities with nil turnover. Period-over-period data reveals a stark contrast: Lenskart Solutions posted strong 30.6% YoY revenue growth, while Sudarshan Chemical Industries saw a 27.5% YoY revenue decline, and Stem Inc. reported a 12% YoY revenue drop. The overall sentiment is heavily negative, with a high concentration of risk flags in the Indian corporate insolvency space and US-listed companies facing delisting, but select opportunities exist in the turnaround of Nova Iron & Steel and the high-growth acquisition by UVS Hospitality.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 12, 2026

The August 12, 2026, filing set reveals a market bifurcated between high-growth, cash-burning companies and stable, income-oriented institutions. A dominant theme is the aggressive capital expenditure and debt-fueled expansion in the tech and infrastructure sectors, exemplified by WhiteFiber's 54.5% revenue surge but 51% cash decline, and Applied Aerospace's 47.4% revenue growth offset by a $154M net loss from IPO costs. Conversely, the healthcare sector shows a stark contrast between commercial-stage success (Protalix's $22.1M net income swing) and pre-revenue cash burn (Onconetix's going-concern risk). The financial filings are dominated by passive 13F snapshots, revealing a broad institutional preference for mega-cap tech and fixed-income ETFs, with notable exceptions like Condor Capital's $1.33B ETF-heavy portfolio and Marathon Trading's aggressive use of options for hedging and speculation. Key period-over-period trends include margin compression in mature industrials (Utah Medical Products, Air Industries Group) and a shift toward shareholder returns, with Arbutus planning a $230M buyback from a litigation settlement. The most critical developments are the $510M dilutive acquisition by Ming Shing Group, the $225M capital raise by Altimmune for a Phase 3 trial, and the securities class action lawsuit against Datavault AI, all of which carry significant market implications for their respective sectors.

10 high priority 40 medium 50 total filings